• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Batavia Bioservices opens Boston area laboratory facility

Batavia Bioservices opens Boston area laboratory facility

June 18, 2012
CenterWatch Staff

Batavia Bioservices, a Netherlands-based service provider aiding the development of complex biological medicines, has launched a U.S. facility in Woburn, Mass.

“We have been growing more than 400% in the past two years in the Netherlands and to keep up with customer demand we have decided to launch a facility in the Boston area,” said Menzo Havenga, president and CEO of Batavia.  

Christopher Yallop, COO of Batavia, added, “We have chosen the Greater Boston Area due to its importance as a biotech cluster. Positioning ourselves here allows us to be close to our customers, which we deem extremely important in delivering on time and on budget.”

The 5,500 sq. foot facility is located at Cummings Properties’ TradeCenter and contains multiple BSL-2 laboratories dedicated to specific tasks including molecular biology, mammalian cell line generation, protein production, protein purification and assay development. The company has already hired six employees for the new facility, with plans to hire four more by the end of this year.

“We are excited to welcome Batavia Bioservices to the Massachusetts Life Sciences community,” said Susan Windham-Bannister, Ph.D., president and CEO of the Massachusetts Life Sciences Center, the agency charged with implementing Governor Patrick’s 10-year, $1 billion Life Sciences Initiative. “Batavia provides important services to the life sciences industry sectors, and the company's presence in Massachusetts will contribute to our economy, as well as strengthen our life sciences ecosystem. I am confident that the team at Batavia will find all of the resources and partners they need to thrive in Massachusetts.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing